viernes, 7 de julio de 2017

MMWR Vol. 66 / Early Release


MMWR Early Release
Vol. 66, Early Release
July 07, 2017

In this report
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
Lucy A. McNamara, PhD; Nadav Topaz, MSc; Xin Wang, PhD; et al.

Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States for the period 2008–2016.

No hay comentarios: